Olink Holding AB (publ)
NASDAQ:OLK
Relative Value
The Relative Value of one OLK stock under the Base Case scenario is 24.92 USD. Compared to the current market price of 23.72 USD, Olink Holding AB (publ) is Undervalued by 5%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
OLK Competitors Multiples
Olink Holding AB (publ) Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
SE |
Olink Holding AB (publ)
NASDAQ:OLK
|
2.9B USD | 17.4 | -93.3 | -91.2 | -56.7 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
230B USD | 5.4 | 38.4 | 23.6 | 34.6 | ||
US |
Danaher Corp
NYSE:DHR
|
192B USD | 4.4 | 23.8 | 17.3 | 21.3 | ||
US |
Agilent Technologies Inc
NYSE:A
|
44.3B USD | 6.6 | 35.9 | 28.6 | 34.4 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
42B USD | 2.8 | 30.9 | 16.8 | 25.9 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 15 | 64.8 | 34.2 | 49.2 | ||
CH |
Lonza Group AG
SIX:LONN
|
36.6B CHF | 5.4 | 56 | 19.2 | 28.2 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
32B USD | 8.4 | 41.1 | 28 | 31.2 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.1B USD | 3.2 | 38.2 | 17.2 | 26.5 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
25.9B USD | 8.8 | 45.5 | 31.6 | 38.3 | ||
US |
Waters Corp
NYSE:WAT
|
21.3B USD | 7.3 | 35.3 | 23.6 | 29.2 |